Recall Enforment Report D-0088-2024
Recall Details
Drug Recall Enforcement Report Class III voluntary initiated by AbbVie Inc., originally initiated on 10-17-2023 for the product Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11 The product was recalled due to labeling: wrong barcode- one (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.. The product was distributed in Distributed In The Us. No Government Or Foreign Consignees. and the recall is currently ongoing.
Field Name | Field Value |
---|---|
Event ID | 93202 What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes). |
Recall Number | D-0088-2024 What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes). |
Recall Classification | Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified". |
Distribution Pattern | Distributed in the US. No government or foreign consignees. What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included. |
Product Description | Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11 |
Reason For Recall | Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose. What is the Reason for Recall? Information describing how the product is defective. |
Product Quantity | 864 cartons Product Quantity The amount of product subject to recall. |
Voluntary Mandated | Voluntary: Firm initiated Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order. |
Report Date | 11-15-2023 |
Recall Initiation Date | 10-17-2023 What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall. |
Initial Firm Notification | Letter Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall. |
Product Type | Drugs |
Recalling Firm | AbbVie Inc. |
Code Info | Lot # 1187435 exp date: 02/2024 Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling. |
Recalled NDC Packages | 0074-4341-13; 0074-4341-90; 0074-4341-19; 0074-4341-72; 0074-4552-13; 0074-4552-90; 0074-4552-19; 0074-4552-11; 0074-4552-71; 0074-4552-72; 0074-5182-13; 0074-5182-90; 0074-5182-71; 0074-5182-19; 0074-5182-11; 0074-5182-72; 0074-6594-13; 0074-6594-90; 0074-6594-71; 0074-6594-19; 0074-6594-72; 0074-6624-13; 0074-6624-90; 0074-6624-19; 0074-6624-11; 0074-6624-71; 0074-6624-72; 0074-9296-13; 0074-9296-90; 0074-9296-19; 0074-9296-71; 0074-9296-72; 0074-7068-13; 0074-7068-90; 0074-7068-71; 0074-7068-19; 0074-7068-11; 0074-7068-72; 0074-3727-13; 0074-3727-90; 0074-3727-71; 0074-3727-19; 0074-3727-72; 0074-7069-90; 0074-7069-71; 0074-7069-19; 0074-7069-11; 0074-7069-72; 0074-7070-13; 0074-7070-90; 0074-7070-71; 0074-7070-19; 0074-7070-72; 0074-7148-90; 0074-7148-19; 0074-7148-71; 0074-7148-11; 0074-7148-72; 0074-7149-90; 0074-7149-19 |
Status | Ongoing |
Recalled Products
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0074-3727 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-4341 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-4552 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-5182 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-6594 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-6624 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-7068 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-7069 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-7070 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-7148 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-7149 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |
0074-9296 | Synthroid | Levothyroxine Sodium | Tablet | Oral | Abbvie Inc. | Human Prescription Drug |